Previous 10 | Next 10 |
Moleculin to Participate in the Virtual Investor Summer Spotlight Series PR Newswire Live moderated video webcast on Wednesday, July 12 th at 3:00 PM ET HOUSTON , July 6, 2023 /PRNewswire/ -- Moleculin Biotech, Inc. , (Nasdaq: MBRX) ...
Moleculin to Participate in the Healthcare Virtual Conference Presented by Maxim Group LLC and Hosted by M-Vest PR Newswire Live webcast fireside chat on Wednesday, June 21 st at 1:30 PM ET HOUSTON , June 13, 2023 /PRNewswire/ -- Moleculin...
Moleculin Announces Adjournment of 2023 Annual Meeting to June 15, 2023 PR Newswire - Company urges shareholders of record date, March 27, 2023 , to vote your shares immediately if you have not already done so HOUSTON , May 30, 2023 /PRNewswire/ -- Moleculi...
2023-05-11 11:29:10 ET Moleculin Biotech, Inc. (MBRX) Q1 2023 Earnings Conference Call May 11, 2023 8:30 a.m. ET Company Participants Jenene Thomas - Investor Relations Walter Klemp - Chairman and Chief Executive Officer John Paul Waymack - Senior Chief Medical O...
2023-05-11 07:08:35 ET Moleculin Biotech press release ( NASDAQ: MBRX ): Q1 GAAP EPS of -$0.28 in-line. As of March 31, 2023, the Company had cash and cash equivalents of $37.3 million and believes that this cash is sufficient to meet its projected operating requirements i...
Moleculin Reports First Quarter 2023 Financial Results PR Newswire – Continued clinical and operational execution across ongoing development programs with growing body of positive preclinical and clinical data – Sufficient capital to fund operat...
Moleculin Provides Update on Ongoing Clinical Trials and Outlines Expected Upcoming Milestones PR Newswire – Actively recruiting in three Phase 1b /2 clinical trials (one of which is in Phase 2) – Recently completed first cohort in Phase 1b /2 tri...
2023-05-10 11:12:09 ET Major earning expected before the bell on Thursday include: Fiverr International ( FVRR ) Himax Technologies ( HIMX ) JD.com ( JD ) Marathon Digital Holdings ( MARA ) Tapestry ( TPR ) For further details see: Notable...
Moleculin to Report First Quarter Financial Results on May 11, 2023 and Host Conference Call and Webcast PR Newswire HOUSTON , May 4, 2023 /PRNewswire/ -- Moleculin Biotech, Inc. , (Nasdaq: MBRX) ("Moleculin" or the "Company"), a clinical stage pharmaceutical...
Moleculin Successfully Completes First Cohort in Phase 1b/2 Trial Evaluating Annamycin in Combination with Cytarabine (Ara-C) for the Treatment of Acute Myeloid Leukemia (AML) PR Newswire Preliminary results demonstrate a durable complete response at starting dose level in eld...
News, Short Squeeze, Breakout and More Instantly...
Moleculin Biotech Inc. Company Name:
MBRX Stock Symbol:
NASDAQ Market:
Moleculin Biotech Inc. Website:
2024-06-17 10:10:00 ET June 17, 2024 (Investorideas.com Newswire) Investorideas.com , a go-to investing platform releases the first of a two-part series looking at developments for the treatment of blood cancers. Today's snapshot focuses in on acute myeloid leukemia (AML) and the compan...
Moleculin Announces Additional Positive Preliminary Interim Data from AML Clinical Trial PR Newswire – 89% of CRc's were subjects with "poor prognosis" cytogenetics and/or mutations – Current median durability of response (mDOR) of CRc's = 6 months and in...
Moleculin to Present at the Virtual Investor Pitch Conference PR Newswire Live video webcast on Tuesday, June 18 th at 3:00 PM ET HOUSTON , June 12, 2024 /PRNewswire/ -- Moleculin Biotech, Inc. , (Nasdaq: MBRX) ("Moleculin" or the "Company...